Bionano Genomics Inc (BNGO) — Strategic Asset Allocation Index
Bionano Genomics Inc (BNGO) has a Strategic Asset Allocation Index of 26.0% as of September 2023. Strategic assets (PP&E of $30.99 Million plus long-term investments of $-) total $30.99 Million, measured against net assets of $119.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Bionano Genomics Inc (BNGO) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Bionano Genomics Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how Bionano Genomics Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of September 2023, the index stands at 26.0%, representing strategic assets of $30.99 Million against net assets of $119.00 Million USD. For live market cap and overall valuation, see market value of Bionano Genomics Inc.
Annual Strategic Asset Allocation Index for Bionano Genomics Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Bionano Genomics Inc from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Bionano Genomics Inc (BNGO) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 7.2% | $18.03 Million | $18.03 Million | $- | $249.40 Million | ▲ +4.2 pp |
| 2021 | 3.1% | $10.32 Million | $10.32 Million | $- | $337.12 Million | ▼ -10.9 pp |
| 2020 | 14.0% | $4.91 Million | $4.91 Million | $- | $35.08 Million | ▼ -40.0 pp |
| 2019 | 54.0% | $1.95 Million | $1.95 Million | $- | $3.61 Million | ▲ +36.4 pp |
| 2018 | 17.5% | $1.78 Million | $1.78 Million | $- | $10.14 Million | — |